Decibel Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/11/2023 | Q2 2023 | $0.57 | -$0.73 | -1.3 | $0 | |
| 05/15/2023 | Q1 2023 | $0.48 | -$0.53 | -1.01 | $0 | |
| 03/14/2023 | Q4 2022 | $0.20 | -$0.64 | -0.84 | $0 | |
| 11/09/2022 | Q3 2022 | $0.64 | -$0.64 | -1.28 | $0 | |
| 08/10/2022 | Q2 2022 | $0.54 | -$0.68 | -1.22 | $0 | |
| 05/12/2022 | Q1 2022 | $0.54 | -$0.56 | -1.1 | $0 | |
| 03/18/2022 | Q4 2021 | $0.41 | -$0.52 | -0.93 | $0 | |
| 11/10/2021 | Q3 2021 | $0.40 | -$0.66 | -1.06 | $0 | |
| 08/10/2021 | Q2 2021 | $0.39 | -$0.47 | -0.86 | $0 | |
| 05/13/2021 | Q1 2021 | $0.38 | -$0.90 | -1.28 | $0 | |
| 03/29/2021 | Q4 2020 | -$0.56 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.97 | $0 | |||
| 06/29/2020 | Q2 2020 | -$1.06 | $0 | |||
| 03/30/2020 | Q1 2020 | -$1.57 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.85 | $0 |
Decibel Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Decibel Therapeutics, Inc.'s earnings date?
Decibel Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 6th, 2023 based off last year's report dates.
-
Did Decibel Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Decibel Therapeutics, Inc. (:DBTX) reported $0.73 earnings per share (EPS) to beat the analysts' consensus estimate of $0.57 by $0.16.
-
How can I listen to Decibel Therapeutics, Inc.'s earnings conference call?
The conference call for Decibel Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Decibel Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Decibel Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Decibel Therapeutics, Inc. generate each year?
Decibel Therapeutics, Inc. (:DBTX) has a recorded net income of $0. Decibel Therapeutics, Inc. has generated $-2.52 earnings per share over the last four quarters.
-
What is Decibel Therapeutics, Inc.'s price-to-earnings ratio?
Decibel Therapeutics, Inc. (:DBTX) has a price-to-earnings ratio of -1.95 and price/earnings-to-growth ratio is 0.97.
